®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
May 25, 2017
Highlights from the Bloom Burton & Co. Healthcare Investor Conference 2017
Click on the image above to read the entire article.
RELATED NEWS
See All News
PharmaEssentia Expands North American Commercial Footprint with Acquisition of Canadian Partner FORUS Therapeutics
Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million
Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs
Richards Group Inc. Announces Acquisition of the CPG Assets of PharmaSystems Inc.
Three Finalists Announced for the 2026 Bloom Burton Award
Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium
Australian-Listed @PYC Therapeutics (ASX:PYC) Raises A$600 Million from Leading Healthcare Specialist Investors, Institutional Investors and Existing Investors
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
Registration is now open for the 2026 Bloom Burton & Co. Healthcare Investor Conference!
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
